Upcoming System Maintenance for Upgrades, May 21-24
Online purchasing, order management, and the MyIllumina Customer Dashboard will be unavailable from approximately 22:00 (UTC) Friday, 21 May until 1:00 (UTC) Monday, 24 May for upgrades. You can complete product purchases or dashboard tasks in advance, or once the upgrade is complete. We apologize for any inconvenience. Learn More
AmpliSeq for Illumina Cancer Hotspot Panel v2
Targeted research panel investigating hotspot regions of 50 genes with known associations to cancer.Read More...
The AmpliSeq for Illumina Cancer Hotspot Panel v2 is a targeted resequencing assay for researching somatic mutations across the hotspot regions of 50 genes with known associations to cancer, as identified in the Catalogue of Somatic Mutations in Cancer (COSMIC)1 database. Key features include:
Relevant Gene Content
Target ~2800 COSMIC mutations from 50 oncogenes and tumor suppressor genes
Fast, Streamlined Workflow
Prepare sequencing-ready libraries in a single day from as little as 1 ng of high quality or 10 ng of formalin-fixed, paraffin-embedded (FFPE) samples
Detect somatic mutations down to 5% variant allele frequency using local or cloud-based analysis
The Cancer HotSpot Panel is part of an integrated workflow that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS) next-generation sequencing (NGS) technology, and automated analysis.
This panel enables highly sensitive variant detection within multiple cancer types, including lung, colon, breast, ovarian, melanoma, and prostate. The ready-to-use panel saves you the time and effort of identifying targets, designing primers, and optimizing panels.